BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
McKinsey
Julphar
Merck
Citi
Boehringer Ingelheim
AstraZeneca
Covington
Baxter
Deloitte

Generated: January 20, 2018

DrugPatentWatch Database Preview

Polyethylene glycol 3350 - Generic Drug Details

« Back to Dashboard

What are the generic sources for polyethylene glycol 3350 and what is the scope of polyethylene glycol 3350 freedom to operate?

Polyethylene glycol 3350
is the generic ingredient in twenty-two branded drugs marketed by Kremers Urban Pharms, Bayer Healthcare Llc, Ailex Pharms Llc, Ani Pharms Inc, Breckenridge Pharm, Mylan, Nexgen Pharma, Nexgen Pharma Inc, Novel Labs Inc, Nuvo Pharm Inc, Paddock Llc, Par Pharm, Perrigo R And D, Strides Pharma, Teva Pharms, Braintree, Mylan Pharms Inc, Hospira, Mylan Speciality Lp, Vintage Pharms, Dynapharm, E Z Em, Goldline, and Sandoz, and is included in thirty-eight NDAs. Additional information is available in the individual branded drug profile pages.

There are four hundred and seventeen drug master file entries for polyethylene glycol 3350. Seventy-three suppliers are listed for this compound. There is one tentative approval for this compound.
Pharmacology for polyethylene glycol 3350
Tentative approvals for POLYETHYLENE GLYCOL 3350
Applicant Application No. Strength Dosage Form
➤ Subscribe➤ Subscribe2MG; 5MGSOLUTION; ORAL AND TABLET; DELAYED RELEASE

US Patents and Regulatory Information for polyethylene glycol 3350

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Speciality Lp COLYTE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 018983-010 Jan 31, 1989 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-001 Jul 13, 1984 AA RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Goldline GLYCOPREP polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SUSPENSION;ORAL 072319-001 Dec 23, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Nexgen Pharma POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 090812-001 Oct 7, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 090409-001 Apr 2, 2010 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva Pharms POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 077445-001 May 4, 2006 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
E Z Em E-Z-EM PREP LYTE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SUSPENSION;ORAL 071278-001 Nov 21, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Breckenridge Pharm PEG-3350, POTASSIUM CHLORIDE, SODIUM BICARBONATE, SODIUM CHLORIDE polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride FOR SOLUTION;ORAL 202060-001 Mar 8, 2017 AA RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 078915-001 Oct 6, 2009 OTC No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Braintree GOLYTELY polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous FOR SOLUTION;ORAL 019011-002 Jun 2, 1992 RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
Teva
Covington
Daiichi Sankyo
Healthtrust
Mallinckrodt
Fish and Richardson
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot